Clinical News

Clinical Status

<div class="articleContainer"><div class="articleWrapper"><div class="articleContent"><h1 class="text title">Octreotide acetate: Phase II completed enrollment</h1><div class="byline">WIR Staff</div><div class="date"></div></div></div></div>

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

Valera completed enrollment of 12 patients in a Phase II trial. ......

Endocrine / Metabolic

Octreotide acetate: Phase II completed enrollment

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Discovery & Translation Analysis

Discovery & Translation

Hot Topics

BioCentury Podcasts

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data

All Events

East-West Healthcare Reception

Bio€quity Europe

Grand Rounds — U.S.

Grand Rounds — Europe

The BioCentury-BayHelix China Healthcare Summit

China Healthcare Summit

At the East-West Summit, you will meet key players looking to globalize innovation from across Asia.